Carl Zeiss Meditec AG (CZMWY)
102.27
+0.98
(+0.96%)
USD |
OTCM |
May 22, 16:00
Carl Zeiss Meditec Revenue (Quarterly): 512.82M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 512.82M |
| December 31, 2023 | 511.53M |
| September 30, 2023 | 631.17M |
| June 30, 2023 | 583.52M |
| March 31, 2023 | 541.55M |
| December 31, 2022 | 480.89M |
| September 30, 2022 | 574.14M |
| June 30, 2022 | 508.61M |
| March 31, 2022 | 499.60M |
| December 31, 2021 | 469.15M |
| September 30, 2021 | 528.91M |
| June 30, 2021 | 519.23M |
| March 31, 2021 | 480.15M |
| December 31, 2020 | 439.84M |
| September 30, 2020 | 429.82M |
| June 30, 2020 | 278.61M |
| March 31, 2020 | 381.00M |
| December 31, 2019 | 409.38M |
| September 30, 2019 | 480.04M |
| June 30, 2019 | 404.89M |
| March 31, 2019 | 390.24M |
| December 31, 2018 | 369.21M |
| September 30, 2018 | 412.27M |
| June 30, 2018 | 373.25M |
| March 31, 2018 | 391.83M |
| Date | Value |
|---|---|
| December 31, 2017 | 347.04M |
| September 30, 2017 | 382.31M |
| June 30, 2017 | 305.01M |
| March 31, 2017 | 327.56M |
| December 31, 2016 | 302.07M |
| September 30, 2016 | 323.41M |
| June 30, 2016 | 291.27M |
| March 31, 2016 | 306.88M |
| December 31, 2015 | 287.32M |
| September 30, 2015 | 323.80M |
| June 30, 2015 | 277.09M |
| March 31, 2015 | 289.82M |
| December 31, 2014 | 301.10M |
| September 30, 2014 | 312.14M |
| June 30, 2014 | 291.87M |
| March 31, 2014 | 340.64M |
| December 31, 2013 | 288.98M |
| September 30, 2013 | 341.19M |
| June 30, 2013 | 269.18M |
| March 31, 2013 | 295.66M |
| December 31, 2012 | 284.08M |
| September 30, 2012 | 288.86M |
| June 30, 2012 | 255.55M |
| March 31, 2012 | 290.36M |
| December 31, 2011 | 283.38M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
278.61M
Minimum
Jun 2020
631.17M
Maximum
Sep 2023
483.24M
Average
490.25M
Median
Revenue (Quarterly) Benchmarks
| Affimed NV | 0.4448M |
| InflaRx NV | 0.0391M |
| MorphoSys AG | 63.62M |
| BioNTech SE | 203.77M |
| Immatics NV | 32.88M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 50.48M |
| Total Expenses (Quarterly) | 442.53M |
| EPS Diluted (Quarterly) | 0.5648 |
| Enterprise Value | 9.125B |
| Gross Profit Margin (Quarterly) | 53.49% |
| Profit Margin (Quarterly) | 9.84% |
| Earnings Yield | 3.11% |
| Operating Earnings Yield | 3.72% |
| Normalized Earnings Yield | 3.115 |